Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context, The Lancet Respiratory Medicine

Article reviews clinical& methodological heterogeneity of studies of IL-6 antagonists,& considers how this might have influenced reported treatment effects. Severity of illness and concomitant corticosteroids are among factors that might have contributed to inconsistent results
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news